American Journal of Cardiology
Volume 105, Issue 8 , Pages 1065-1069 , 15 April 2010

Comparison of Usefulness of N-Terminal Pro-Brain Natriuretic Peptide as an Independent Predictor of Cardiac Function Among Admission Cardiac Serum Biomarkers in Patients With Anterior Wall Versus Nonanterior Wall ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

  • Joost D.E. Haeck, MD

      Affiliations

    • Department of Cardiology, University of Amsterdam Academic Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author: Tel: (31) 20-566-2609; fax: (31) 20-696-2609
    • ,
  • Niels J.W. Verouden, MD

      Affiliations

    • Department of Cardiology, University of Amsterdam Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Wichert J. Kuijt, MD

      Affiliations

    • Department of Cardiology, University of Amsterdam Academic Medical Center, Amsterdam, The Netherlands
    • Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • Karel T. Koch, MD, PhD

      Affiliations

    • Department of Cardiology, University of Amsterdam Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Jan P. Van Straalen, MSc

      Affiliations

    • Clinical Chemistry, University of Amsterdam Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Johan Fischer, PhD

      Affiliations

    • Clinical Chemistry, University of Amsterdam Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Maarten Groenink, MD, PhD

      Affiliations

    • Department of Cardiology, University of Amsterdam Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Luc Bilodeau, MD

      Affiliations

    • Department of Cardiology, Institut de Cardiology de Montréal, Montréal, Quebec, Canada
    • ,
  • Jan G.P. Tijssen, PhD

      Affiliations

    • Department of Cardiology, University of Amsterdam Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Mitchell W. Krucoff, MD

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • Robbert J. De Winter, MD, PhD

      Affiliations

    • Department of Cardiology, University of Amsterdam Academic Medical Center, Amsterdam, The Netherlands

Received 24 September 2009 ,Revised 3 December 2009 ,Accepted 3 December 2009.

Reference 

  1. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, et al. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation. 2008;117:629–637
  2. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992–2002
  3. Haeck JD, Koch KT, Bilodeau L, van der Schaaf RJ, Henriques JP, Vis MM, et al. Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction: the PREPARE (PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation) study. JACC Cardiovasc Interv. 2009;2:934–943
  4. Haeck JD, Kuijt WJ, Koch KT, Bilodeau L, Henriques JP, Rohling WJ, et al. Infarct size and left ventricular function in the Proximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study. Heart Epub. 2009 Oct 26;
  5. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  6. Kim KE, Onesti G, Ramirez O, Brest AN, Swartz C. Creatinine clearance in renal disease: a reappraisal. BMJ. 1969;4:11–14
  7. Cerisano G, Pucci PD, Sulla A, Tommasi M, Raspanti S, Santoro GM, et al. Relation between plasma brain natriuretic peptide, serum indexes of collagen type I turnover, and left ventricular remodeling after reperfused acute myocardial infarction. Am J Cardiol. 2007;99:651–656
  8. Garcia-Alvarez A, Sitges M, Delgado V, Ortiz J, Vidal B, Poyatos S, et al. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance. Am J Cardiol. 2009;104:878–882
  9. Hirayama A, Kusuoka H, Yamamoto H, Sakata Y, Asakura M, Higuchi Y, et al. Usefulness of plasma brain natriuretic peptide concentration for predicting subsequent left ventricular remodeling after coronary angioplasty in patients with acute myocardial infarction. Am J Cardiol. 2006;98:453–457
  10. Paelinck BP, Vrints CJ, Bax JJ, Bosmans JM, De Hert SG, de Roos A, et al. Relation of B-type natriuretic peptide early after acute myocardial infarction to left ventricular diastolic function and extent of myocardial damage determined by magnetic resonance imaging. Am J Cardiol. 2006;97:1146–1150
  11. Cochet A, Zeller M, Cottin Y, Robert-Valla C, Lalande A, L'Huilllier I, et al. The extent of myocardial damage assessed by contrast-enhanced MRI is a major determinant of N-BNP concentration after myocardial infarction. Eur J Heart Fail. 2004;6:555–560
  12. Nakagawa K, Umetani K, Fujioka D, Sano K, Nakamura T, Kodama Y, et al. Correlation of plasma concentrations of B-type natriuretic peptide with infarct size quantified by tomographic thallium-201 myocardial scintigraphy in asymptomatic patients with previous myocardial infarction. Circ J. 2004;68:923–927
  13. Panteghini M, Cuccia C, Bonetti G, Pagani F, Giubbini R, Bonini E. Rapid determination of brain natriuretic peptide in patients with acute myocardial infarction. Clin Chem Lab Med. 2003;41:164–168
  14. Thiele H, Schindler K, Friedenberger J, Eitel I, Furnau G, Grebe E, et al. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation. 2008;118:49–57

PII: S0002-9149(09)02831-8

doi: 10.1016/j.amjcard.2009.12.003

American Journal of Cardiology
Volume 105, Issue 8 , Pages 1065-1069 , 15 April 2010

Article Tools

* Image Usage & Resolution